Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2
Boushra Bathish, Holly Robertson, John Dillon, et al.
Free Radical Biology and Medicine (2022) Vol. 188, pp. 221-261
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis
Zhuoran Wang, Mengran Yao, Leyu Jiang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113572-113572
Open Access | Times Cited: 173
Advances and challenges in therapeutic targeting of NRF2
Albena T. Dinkova‐Kostova, Ian M. Copple
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 3, pp. 137-149
Open Access | Times Cited: 141
Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities
Lili Ren, Xiaojun Li, Tingting Duan, et al.
Chemico-Biological Interactions (2022) Vol. 369, pp. 110289-110289
Closed Access | Times Cited: 86
The mechanism of ferroptosis and its related diseases
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 62
The KEAP1-NRF2 System and Neurodegenerative Diseases
Akira Uruno, Masayuki Yamamoto
Antioxidants and Redox Signaling (2023) Vol. 38, Iss. 13-15, pp. 974-988
Closed Access | Times Cited: 58
Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Hepatology (2023) Vol. 15, Iss. 2, pp. 180-200
Open Access | Times Cited: 44
Targeting the Interplay Between Autophagy and the Nrf2 Pathway in Parkinson’s Disease with Potential Therapeutic Implications
Mengru Liu, Siqi Liu, Zi-Han Lin, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 3
Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy
Jihao Xu, Yifan Li, Zhaolan Feng, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 221-221
Open Access | Times Cited: 2
Dietary and lifestyle oxidative balance scores are independently and jointly associated with nonalcoholic fatty liver disease: a 20 years nationally representative cross-sectional study
Yuanbin Liu, Mingkai Chen
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 24
Specific targeting of the NRF2/β-TrCP axis promotes beneficial effects in NASH
Raquel Fernández-Ginés, José Antonio Encinar, Maribel Escoll, et al.
Redox Biology (2024) Vol. 69, pp. 103027-103027
Open Access | Times Cited: 12
An Nrf2-NF-κB crosstalk controls hepatocyte proliferation in the normal and injured liver
Andrii Kuklin, C. Slabber, Luigi Tortola, et al.
Cellular and Molecular Gastroenterology and Hepatology (2025), pp. 101480-101480
Open Access | Times Cited: 1
Protective role of sulforaphane in lipid metabolism-related diseases
Lingfeng Zhao, Jiahuan Li, Yiping Dang, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
Health position paper and redox perspectives – Bench to Bedside Transition for Pharmacological Regulation of NRF2 in Noncommunicable Diseases
Antonio Cuadrado, Eduardo Cazalla, Anders Bach, et al.
Redox Biology (2025), pp. 103569-103569
Open Access | Times Cited: 1
Hormesis and Oxidative Distress: Pathophysiology of Reactive Oxygen Species and the Open Question of Antioxidant Modulation and Supplementation
Mariapaola Nitti, Barbara Marengo, Anna Lisa Furfaro, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1613-1613
Open Access | Times Cited: 31
Nobiletin Ameliorates Hepatic Lipid Deposition, Oxidative Stress, and Inflammation by Mechanisms That Involve the Nrf2/NF-κB Axis in Nonalcoholic Fatty Liver Disease
Chaowen Fan, Anli Ling-Hu, Dali Sun, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 50, pp. 20105-20117
Closed Access | Times Cited: 16
Unraveling the Beneficial Role of Resveratrol in Fructose-Induced Non-Alcoholic Steatohepatitis with a Focus on the AMPK/Nrf2 Signaling Axis
Soha S. Zakaria, Safaa M. Hanafy
Medicina (2025) Vol. 61, Iss. 1, pp. 139-139
Open Access
Therapeutic applications of artemisinin in ophthalmic diseases
Hao Sun, Zhao Ping, Lianghui Zhao, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e42066-e42066
Open Access
Regulating Nrf2 activity: ubiquitin ligases and signaling molecules in redox homeostasis
John D. Hayes, Sharadha Dayalan Naidu, Albena T. Dinkova‐Kostova
Trends in Biochemical Sciences (2025)
Open Access
A Keap1-recruiting BRD4 Degrader Offers a Single-molecular Polypharmacology Approach for the Treatment of Metabolic Dysfunction-associated Steatohepatitis
Xian Zhang, Yuxin Ge, Mengjie Ye, et al.
Free Radical Biology and Medicine (2025) Vol. 232, pp. 15-27
Closed Access
Update in non-alcoholic fatty liver disease management: role of sodium-glucose cotransporter 2 inhibitors
Oscar René Zambrano-Vásquez, Fernando Cortés-Camacho, Jorge Ismael Castañeda‐Sánchez, et al.
Life Sciences (2025), pp. 123638-123638
Closed Access
A morpholine derivative N-(4-morpholinomethylene)ethanesulfonamide induces ferroptosis in tumor cells by targeting NRF2
Bingchun Sun, Ligang Zhang, Binhua Wu, et al.
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 2, pp. 417-426
Open Access | Times Cited: 3
Drivers of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease: the threats of oxidative stress
Erika Minetti, Naomi M. Hamburg, Reiko Matsui
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Activating transcription factor 3: A potential therapeutic target for inflammatory pulmonary diseases
Dandan Li, Juanjuan Jing, Xue Dong, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 9
Open Access | Times Cited: 8
Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease
Jorge Infante‐Menéndez, Paula González‐López, Raquel Huertas‐Lárez, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 262-262
Open Access | Times Cited: 7
A novel crosstalk between Nrf2 and Smad2/3 bridged by two nuanced Keap1 isoforms with their divergent effects on these distinct family transcription factors
Feilong Chen, Qing Wang, Mei Xiao, et al.
Free Radical Biology and Medicine (2024) Vol. 213, pp. 190-207
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top